Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25337 | 236 | 40.6 | 83% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
21 | 35063 | OSTEOPOROSIS//OSTEOPOROSIS INTERNATIONAL//BONE MINERAL DENSITY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BARWON BIOMED | Address | 1 | 29% | 2% | 4 |
2 | SEROTONIN 2B RECEPTOR | Author keyword | 1 | 40% | 1% | 2 |
3 | BONE QCT MICROCT | Author keyword | 1 | 50% | 0% | 1 |
4 | FIZ TEDAVI REHABIL AD | Address | 1 | 50% | 0% | 1 |
5 | GREATER LOS ANGELES VET ADM HLTH SYST | Address | 1 | 50% | 0% | 1 |
6 | MEDICATION MISADVENTURES | Author keyword | 1 | 50% | 0% | 1 |
7 | SELECTIVE SEROTONIN RECEPTOR INHIBITORS | Author keyword | 1 | 50% | 0% | 1 |
8 | SURGEON GEN OFF | Address | 1 | 50% | 0% | 1 |
9 | RADIOISOTOPE S VIVARIUM | Address | 1 | 22% | 1% | 2 |
10 | CLIN ENDOCRINE SECT | Address | 0 | 20% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REUPTAKE INHIBITOR USE | 5 | 55% | 3% | 6 |
2 | SEROTONIN 5 HYDROXYTRYPTAMINE | 2 | 33% | 2% | 4 |
3 | TRYPTOPHAN HYDROXYLASE INHIBITORS | 1 | 38% | 1% | 3 |
4 | SSRI USE | 1 | 100% | 1% | 2 |
5 | TPH1 | 1 | 50% | 1% | 2 |
6 | TRANSPORTER INHIBITION EVIDENCE | 1 | 100% | 1% | 2 |
7 | 5 HT2B | 1 | 21% | 1% | 3 |
8 | SYSTEM ACTIVE MEDICATIONS | 1 | 16% | 2% | 4 |
9 | FUNCTIONING FOLLOWING TREATMENT | 1 | 50% | 0% | 1 |
10 | INTERLEUKIN 6 POLYMORPHISMS | 0 | 33% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome | 2015 | 2 | 26 | 77% |
Antidepressant medications and osteoporosis | 2012 | 26 | 56 | 66% |
Use of selective serotonin reuptake inhibitors and risk of fracture: A systematic review and meta-analysis | 2012 | 19 | 45 | 56% |
Depression and Osteoporosis: A Research Synthesis with Meta-Analysis | 2010 | 30 | 51 | 69% |
The adverse skeletal effects of selective serotonin reuptake inhibitors | 2012 | 13 | 53 | 60% |
Effects of selective serotonin reuptake inhibitors on bone health in adults: Time for recommendations about screening, prevention and management? | 2010 | 31 | 55 | 64% |
Depression, Antidepressants, and Bone Health in Older Adults: A Systematic Review | 2014 | 2 | 43 | 65% |
Fracture risks of antidepressants | 2009 | 15 | 24 | 92% |
Depression, fracture risk, and bone loss: a meta-analysis of cohort studies | 2010 | 29 | 40 | 48% |
Depression as a risk factor for osteoporosis | 2009 | 28 | 57 | 60% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BARWON BIOMED | 1 | 29% | 1.7% | 4 |
2 | FIZ TEDAVI REHABIL AD | 1 | 50% | 0.4% | 1 |
3 | GREATER LOS ANGELES VET ADM HLTH SYST | 1 | 50% | 0.4% | 1 |
4 | SURGEON GEN OFF | 1 | 50% | 0.4% | 1 |
5 | RADIOISOTOPE S VIVARIUM | 1 | 22% | 0.8% | 2 |
6 | CLIN ENDOCRINE SECT | 0 | 20% | 0.8% | 2 |
7 | BIOL AGING AGINGBIOCHEM AGING | 0 | 33% | 0.4% | 1 |
8 | BONE CALCIUM S | 0 | 33% | 0.4% | 1 |
9 | CELLULES SOUCHES SIGNALISAT PRIONS | 0 | 33% | 0.4% | 1 |
10 | ORAL RADIOL SECT | 0 | 33% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000181538 | BONE INNERVATION//NEUROKININ 1 RECEPTOR NK1 R//XINGQIAO HOSP |
2 | 0.0000130343 | META NISOLDIPINE//VOLTAGE ACTIVATED//M NISOLDIPINE |
3 | 0.0000115759 | SCLEROSTIN//SOST//LRP5 |
4 | 0.0000100892 | SEXUAL DYSFUNCTION//HYPERPROLACTINEMIA//HYPERPROLACTINAEMIA |
5 | 0.0000098840 | NEURONTOGENY//DEV NEUROCHEM//PET 1 |
6 | 0.0000084191 | BILATERAL FEMORAL NECK FRACTURE//CLIN DENT DISABLED//ELECT SERV ENGN |
7 | 0.0000081628 | BROMATOL NUTR DIETET//ESTADES PRACT TUTELADES UNIT//CLIN PHARMACOL MED CARE |
8 | 0.0000079731 | BLEEDING ABNORMALITIES//VENOUS THROMBOSIS AND EMBOLISM//ABORATING TRAINING PHARMACOEPIDEMIO |
9 | 0.0000071550 | DIAG TREATMENT OBES//PSYCHONEUROIMMUNOL NUTR GENET PSYNUGEN//ADRENAL GLAND VOLUME |
10 | 0.0000066035 | PLASMA SPRAYED TITANIUM IMPLANTS//REMOVAL TORQUE TEST//CIGARETTE SMOKE MEDIUM |